Accelrys, Inc. (NASDAQ: ACCL), a leading scientific enterprise research and development software and services company, today announced that Max Carnecchia, Chief Executive Officer, and Michael A. Piraino, Chief Financial Officer, will present at the Sidoti & Company Sixteenth Annual New York Institutional Investor Forum on Tuesday, March 20, 2012 at 11:20 am ET. The conference is taking place at the Grand Hyatt Hotel in New York.
To arrange a one-on-one meeting with Accelrys management at the conference, please contact a Sidoti & Company sales person, or the MKR Group, Accelrys’ investor relations firm, at
About Accelrys Inc.
- Sidoti & Company Sixteenth Annual New York Institutional Investor Forum
- Grand Hyatt Hotel, New York
- Accelrys to present on Tuesday, March 20, 2012 at 11:20am ET
- More information can be found at http://www.sidoti.com/
Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. Accelrys' Enterprise Research & Development Architecture, built on the industry-leading Pipeline Pilot™ platform, provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow definition and capture, data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Headquartered in San Diego, Calif., Accelrys has more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries and employs approximately 150 full-time Ph.D. scientists. For more information about Accelrys, visit